A carregar...
Topotecan in the treatment of relapsed small cell lung cancer
Small cell lung cancer (SCLC) represents about 15% to 20% of all lung cancers. Chemotherapy is the cornerstone of the treatment, cisplatin–etoposide combination being the most used combination as first-line therapy. Despite high initial chemosensitivity, most SCLC patients will experience relapse so...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2008
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2994215/ https://ncbi.nlm.nih.gov/pubmed/21127755 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|